La revascularización incompleta no tiene el mismo significado en todos los pacientes

Incomplete Revascularization Does Not Mean the Same Thing for All Patients

Several studies show that patients with multivessel lesions who undergo angioplasty with incomplete revascularization experience more events, including higher mortality, than a cohort of patients who have undergone complete revascularization. In most cases, the analysis was dichotomic (complete vs. incomplete revascularization), but more recent studies show that there may be a gradient, a continuum, in<a href="https://solaci.org/en/2018/02/14/incomplete-revascularization-does-not-mean-the-same-thing-for-all-patients/" title="Read more" >...</a>

¿Se justifica utilizar filtro de protección distal en los puentes venosos?

It is justified to use distal protection filter in venous bridges?

The current guidelines point out a class I recommendation to the use of distal embolic protection devices for angioplasty in venous bridges, in fact, the evidence is controversial to support this recommendation. The goal of this meta-analysis was to compare mortality from any cause, major cardiovascular events, acute myocardial infarction, and target vessel revascularization of<a href="https://solaci.org/en/2018/02/07/it-is-justified-to-use-distal-protection-filter-in-venous-bridges/" title="Read more" >...</a>

The 9 most read scientific articles of 2017 in interventional cardiology

1) New High Blood Pressure Guidelines The wait is finally over: the high blood pressure guidelines that have been in the works for the past 3 years saw the light of day at the American Heart Association (AHA) 2017 Scientific Sessions. Read more 2) Nearly half of interventional cardiologists may have pre-cataract lesions This statement is based on eye<a href="https://solaci.org/en/2018/01/23/the-9-most-read-scientific-articles-of-2017-in-interventional-cardiology/" title="Read more" >...</a>

iFR en lesiones no culpables: el momento de la medición parece cambiar la historia

iFR in Nonculprit Lesions: Measurement Timing May Change History

During primary angioplasty, it is not uncommon to see several other lesions in coronary arteries. Current guidelines advise against the treatment of these lesions in the same primary angioplasty procedure, although there is evidence supporting such a course of action that may warrant changes in these recommendations. The functional assessment of these nonculprit lesions may<a href="https://solaci.org/en/2017/12/19/ifr-in-nonculprit-lesions-measurement-timing-may-change-history/" title="Read more" >...</a>

Estenosis aórtica pura vs mixta en TAVI: beneficios y evolución

TAVR in Patients with Pure vs. Mixed Aortic Stenosis: Benefits and Evolution

Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) has been proven to reduce mortality and improve the quality of life of patients with pure severe aortic stenosis (PAS). However, there is a significant number of patients who experience mixed aortic stenosis associated with moderate/severe aortic regurgitation (MAS). These subjects were excluded from the PARTNER<a href="https://solaci.org/en/2017/12/12/tavr-in-patients-with-pure-vs-mixed-aortic-stenosis-benefits-and-evolution/" title="Read more" >...</a>

El FFR ahorra síntomas a los pacientes y costos a los financiadores de salud

Patients and Healthcare Providers Benefit from Less Symptoms and Lower Costs with FFR

Previous studies in which revascularization was guided by angiography alone found that coronary angioplasty does not improve outcomes compared with optimal medical treatment in patients with chronic stable angina. The FAME 2 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) compared angioplasty guided by fractional flow reserve (FFR) with optimal medical treatment, arriving to<a href="https://solaci.org/en/2017/12/05/patients-and-healthcare-providers-benefit-from-less-symptoms-and-lower-costs-with-ffr/" title="Read more" >...</a>

Estos los últimos artículos publicados sobre angioplastias

7 articles on angioplasty that can draw your attention

1) Balloon Angioplasty: A Reasonable Plan B for Chronic Thromboembolic Hypertension Thromboembolic pulmonary hypertension is caused by pulmonary artery stenosis caused by organized thrombi. The only treatment potentially healing for this disease is surgical thrombectomy. However, patients with lesions in very peripheral branches or high surgical risk patients with comorbidities might benefit from a plan B,<a href="https://solaci.org/en/2017/11/27/7-articles-on-angioplasty-that-can-draw-your-attention/" title="Read more" >...</a>

Ischemic and Bleeding Risk After Primary Angioplasty

Patients with ST-segment elevation myocardial infarction who undergo primary angioplasty are at high risk for both ischemic and bleeding events, which affect significantly both morbidity and mortality. An optimal selection of antithrombotic therapies in terms of strength and duration must take into account the timing for the procedure, since the risk for these complications may<a href="https://solaci.org/en/2017/11/22/ischemic-and-bleeding-risk-after-primary-angioplasty/" title="Read more" >...</a>

FOURIER: Evolocumab Found Beneficial for Patients with Peripheral Vascular Disease of Prior MI

Patients with peripheral vascular disease or prior acute myocardial infarction (especially within the first two years after the event) could find a particular benefit the PCSK9 receptor inhibitor evolocumab.   Given its high cost, the drug is not yet cost/effective and when prescribed, most patients were no table to complete the treatment. Read also: “Missed Opportunities with<a href="https://solaci.org/en/2017/11/16/fourier-evolocumab-found-beneficial-for-patients-with-peripheral-vascular-disease-of-prior-mi/" title="Read more" >...</a>

SOLACI-SUC Joint Session at the Cardiology Congress in Uruguay

From November 9th to November 11th, Punta del Este received the best cardiologists in Latin America. These 3 days of intense scientific activity included the SOLACI-SUC Joint Symposium, which was composed of a structural module (with presentations on TAVI, Mitraclip, paravalvular leaks, and clinical cases) and a coronary module (with activities centered on coronary bifurcation lesions,<a href="https://solaci.org/en/2017/11/15/solaci-suc-joint-session-at-the-cardiology-congress-in-uruguay/" title="Read more" >...</a>